Purchases and Sales Made in Q3 2024 in Cyclo Therapeutics, Inc. (CYTH)
This table provides information about the institutional ownership of Cyclo Therapeutics, Inc. (CYTH) during Q3 2024. The information is specifically focused on institutions that hold shares of Cyclo Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2024
Q3 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
152K+ 34.06% |
$97.4K - $210K
|
599K
$443K
|
|
|
Oct 23, 2024
Q3 2024
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
3K+ 14.71% |
$1.92K - $4.14K
|
23.4K
$17.3K
|
|
|
Nov 14, 2024
Q3 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
784+ 373.33% |
$502 - $1.08K
|
994
$736
|
|
|
Nov 14, 2024
Q3 2024
|
Ubs Group Ag
|
BUY
|
- |
405+ 3.36% |
$259 - $559
|
12.5K
$9.22K
|
|
|
Nov 14, 2024
Q3 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
396+ 7.92% |
$253 - $546
|
5.4K
$3.99K
|
|
|
Nov 14, 2024
Q3 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
75+ 10.05% |
$48 - $103
|
821
$608
|
|
|
Dec 26, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
41+ 26.8% |
$26.2 - $56.6
|
194
$144
|
|
|
Nov 08, 2024
Q3 2024
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
41+ 26.8% |
$26.2 - $56.6
|
194
$144
|
|
|
Oct 10, 2024
Q3 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 29, 2024
Q3 2024
|
Princeton Global Asset Management LLC
|
SELL
|
- |
-300- 7.97% |
$192 - $414
|
3.47K
$2.56K
|
|
|
Nov 12, 2024
Q3 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-23.1K- 13.16% |
$14.8K - $31.9K
|
152K
$113K
|
|
|
Nov 14, 2024
Q3 2024
|
Epiq Capital Group, LLC
San Francisco, CA |
SELL
|
- |
-77.8K- 9.52% |
$49.8K - $107K
|
739K
$547K
|